Cheyne Capital Management (Uk) LLP Acumen Pharmaceuticals, Inc. Transaction History
Cheyne Capital Management (Uk) LLP
- $26.1 Million
- Q4 2023
Shares
1 transactions
Others Institutions Holding ABOS
# of Institutions
81Shares Held
40.6MCall Options Held
28.6KPut Options Held
76.4K-
Ra Capital Management, L.P. Boston, MA14.9MShares$17.9 Million0.42% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$4.1 Million2.23% of portfolio
-
Franklin Resources Inc San Mateo, CA3.27MShares$3.93 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$2.59 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$2.33 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $48.6M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...